Quantcast
Channel: Latest Articles
Browsing all 28 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

INGN Lifts Outlook, BCLI Awaits DSMB Review, TRVN To Report Data Next Month

INGN Lifts Outlook, BCLI Awaits DSMB Review, TRVN To Report Data Next Month

View Article



Image may be NSFW.
Clik here to view.

RVNC Works It Out, ONCE Awaits Data, AKBA, VTAE Make Big Moves, TTPH Doused

RVNC Works It Out, ONCE Awaits Data, AKBA, VTAE Make Big Moves, TTPH Doused

View Article

Image may be NSFW.
Clik here to view.

Zafgen: Beloranib Granted Orphan Drug Designation In EU - Quick Facts

Zafgen: Beloranib Granted Orphan Drug Designation In EU - Quick Facts

View Article

Image may be NSFW.
Clik here to view.

Zafgen Says Patient in Beloranib Study Dies

Zafgen Says Patient in Beloranib Study Dies

View Article

Image may be NSFW.
Clik here to view.

Zafgen: FDA Puts Trial on Partial Hold After Patient Death

Zafgen: FDA Puts Trial on Partial Hold After Patient Death

View Article


Image may be NSFW.
Clik here to view.

FDA Puts Zafgen Trial on Hold After Patient Death

FDA Puts Zafgen Trial on Hold After Patient Death

View Article

Image may be NSFW.
Clik here to view.

Zafgen to Close Portion of Clinical Trial

Zafgen to Close Portion of Clinical Trial

View Article

Image may be NSFW.
Clik here to view.

Earnings Reported After The Bell Nov.10

Earnings Reported After The Bell Nov.10

View Article


Image may be NSFW.
Clik here to view.

Zafgen Says Another Patient Dies in Beloranib Study

Zafgen Says Another Patient Dies in Beloranib Study

View Article


Image may be NSFW.
Clik here to view.

Zafgen Says a Second Patient Died in Beloranib Study

Zafgen Says a Second Patient Died in Beloranib Study

View Article

Image may be NSFW.
Clik here to view.

Pakistani Taliban Attack University, Killing 19

Pakistani Taliban Attack University, Killing 19

View Article

Image may be NSFW.
Clik here to view.

SRPT's Anxious Wait To Continue, ZFGN Has Reason To Flaunt, OGXI Disappoints

SRPT's Anxious Wait To Continue, ZFGN Has Reason To Flaunt, OGXI Disappoints

View Article

Image may be NSFW.
Clik here to view.

Earnings Reported After The Bell Mar.9

Earnings Reported After The Bell Mar.9

View Article


Image may be NSFW.
Clik here to view.

Zafgen''s Beloranib Trial Shows Significant Improvements In Weight Loss

Zafgen''s Beloranib Trial Shows Significant Improvements In Weight Loss

View Article

Image may be NSFW.
Clik here to view.

Zafgen Suspends Development Of Beloranib; Shares Plunge More Than 40%

Zafgen Suspends Development Of Beloranib; Shares Plunge More Than 40%

View Article


Image may be NSFW.
Clik here to view.

SCLN Withdraws From Auction Block, ZFGN Tumbles, Double Blessing For VRX

SCLN Withdraws From Auction Block, ZFGN Tumbles, Double Blessing For VRX

View Article

Image may be NSFW.
Clik here to view.

INFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints

INFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints

View Article


Image may be NSFW.
Clik here to view.

ZFGN Awaits Data, SLDB Makes Solid Gains, RCKT On Fire, SGEN Snaps Up CASC

ZFGN Awaits Data, SLDB Makes Solid Gains, RCKT On Fire, SGEN Snaps Up CASC

View Article

Image may be NSFW.
Clik here to view.

ARRY's COLUMBUS Turns Heads, ZFGN On Course, MNOV UP 66% YTD

ARRY's COLUMBUS Turns Heads, ZFGN On Course, MNOV UP 66% YTD

View Article

Image may be NSFW.
Clik here to view.

FDA Approves New HIV Drug, Mark Your Calendar For BHVN, Watch Out For ZFGN

FDA Approves New HIV Drug, Mark Your Calendar For BHVN, Watch Out For ZFGN

View Article
Browsing all 28 articles
Browse latest View live




Latest Images